Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

Overview of attention for article published in JACC, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 18 X users
facebook: 2 Facebook pages

googleplus: 2 Google+ users
guideline: 1 clinical guideline source

Readers on

mendeley: 111 Mendeley

So far, Altmetric has seen 21 X posts from 18 X users, with an upper bound of 189,105 followers.

RT @tipssovetorax: En pacientes con EPOC y riesgo cardiovascular elevado, la troponina I son un indicador de futuros eventos cardiovascular…

RT @tipssovetorax: Las terapias inhaladas no afectaron las concentraciones de troponina I cardíaca y su efecto neutral sobre la mortalidad…

Las terapias inhaladas no afectaron las concentraciones de troponina I cardíaca y su efecto neutral sobre la mortalidad y los resultados cardiovasculares/2 https://t.co/1snJJ2KP1a

En pacientes con EPOC y riesgo cardiovascular elevado, la troponina I son un indicador de futuros eventos cardiovasculares y muerte cardiovascular/1 https://t.co/1snJJ2KP1a

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 17 additional X posts.